What is Emerald Cloud Lab?
Founded in 2010 and headquartered in San Francisco, Emerald Cloud Lab operates at the intersection of high-throughput biotechnology and software engineering. The company provides its proprietary ECL command center, a sophisticated platform that enables researchers to remotely execute complex experiments. This technology serves a diverse array of sectors, including pharmaceutical research, materials science, medical diagnostics, and agriculture. By offering a centralized, cloud-native interface for laboratory operations, Emerald Cloud Lab effectively democratizes access to high-end scientific instrumentation, allowing organizations to accelerate their research cycles while reducing the overhead associated with maintaining physical laboratory facilities.
How much funding has Emerald Cloud Lab raised?
Emerald Cloud Lab has raised a total of $3.5M across 1 funding round:
Debt
$3.5M
Debt (2021): $3.5M with participation from PPP
Key Investors in Emerald Cloud Lab
PPP
Public-Private Partnership
What's next for Emerald Cloud Lab?
With this major enterprise-level funding, Emerald Cloud Lab is well-positioned to scale its operational capacity and expand its suite of automated experimental protocols. The strategic focus will likely center on enhancing the interoperability of the ECL command center with emerging AI-driven drug discovery pipelines and advanced materials modeling tools. As the industry shifts toward decentralized research models, the company is poised to become a foundational layer in the global scientific infrastructure, potentially setting new standards for reproducibility and efficiency in experimental science. Future growth will likely involve deepening its footprint in the pharmaceutical sector while exploring new applications in synthetic biology and sustainable agriculture.
See full Emerald Cloud Lab company page
